In this study, we have established that thyroid cancer cell lines and tumor samples from patients with BRAFV600E -mutated tumors have higher levels of PD-L1 compared with either BRAFWT tumors or matched normal tissue. This evidence concerns the gene CD274 and thyroid cancer.